How best to describe the risk of meningococcal B infection?
作者信息
Sadarangani Manish, Bettinger Julie A, Scheifele David W
机构信息
Division of Infectious & Immunological Diseases, Department of Pediatrics, University of British Columbia and British Columbia Children's Hospital, Vancouver, British Columbia; ; Department of Paediatrics, University of Oxford and the National Institute of Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Division of Infectious & Immunological Diseases, Department of Pediatrics, University of British Columbia and British Columbia Children's Hospital, Vancouver, British Columbia;
出版信息
Paediatr Child Health. 2013 Dec;18(10):543-4. doi: 10.1093/pch/18.10.543.
Abstract
摘要
相似文献
1
How best to describe the risk of meningococcal B infection?
Paediatr Child Health. 2013 Dec;18(10):543-4. doi: 10.1093/pch/18.10.543.
2
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab.
Pediatrics. 2017 Sep;140(3). doi: 10.1542/peds.2016-2452. Epub 2017 Aug 11.
3
Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention.
Int J Environ Res Public Health. 2022 Mar 29;19(7):4035. doi: 10.3390/ijerph19074035.
4
Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013.
J Infect Public Health. 2015 Sep-Oct;8(5):441-7. doi: 10.1016/j.jiph.2015.01.009. Epub 2015 Mar 14.
5
Meningococcal pneumonia: a review.
Pneumonia (Nathan). 2019 Aug 25;11:3. doi: 10.1186/s41479-019-0062-0. eCollection 2019.
6
Meningococcal disease in childhood: epidemiology, clinical features and prevention.
J Prev Med Hyg. 2015 Aug 31;56(3):E121-4.
7
Serogroup B meningococcal vaccines.
Curr Opin Investig Drugs. 2006 Aug;7(8):733-9.
8
Meningococcal vaccines in Australia: a 2019 update.
Aust Prescr. 2019 Aug;42(4):131-135. doi: 10.18773/austprescr.2019.042. Epub 2019 Aug 1.
9
Disseminated meningococcal infection in HIV-seropositive patients.
AIDS. 1993 Jan;7(1):87-90. doi: 10.1097/00002030-199301000-00013.
10
Serogroup B meningococcal disease in persons previously vaccinated with a serogroup B meningococcal vaccine - United States, 2014-2019.
Vaccine. 2021 Dec 20;39(52):7655-7660. doi: 10.1016/j.vaccine.2021.11.004. Epub 2021 Nov 14.
引用本文的文献
1
Meningococcal vaccination in pregnancy.
Hum Vaccin Immunother. 2018 May 4;14(5):1188-1196. doi: 10.1080/21645515.2018.1445447. Epub 2018 Mar 21.
2
The role of pediatricians as key stakeholders in influencing immunization policy decisions for the introduction of meningitis B vaccine in Canada: The Ontario perspective.
Can J Infect Dis Med Microbiol. 2015 Jul-Aug;26(4):183-90. doi: 10.1155/2015/963940.
本文引用的文献
1
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials.
Lancet. 2013 Mar 9;381(9869):825-35. doi: 10.1016/S0140-6736(12)61961-8.
2
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
JAMA. 2012 Feb 8;307(6):573-82. doi: 10.1001/jama.2012.85.
3
The changing and dynamic epidemiology of meningococcal disease.
Vaccine. 2012 May 30;30 Suppl 2:B26-36. doi: 10.1016/j.vaccine.2011.12.032. Epub 2011 Dec 15.
4
The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
Pediatr Infect Dis J. 2009 Mar;28(3):220-4. doi: 10.1097/INF.0b013e31819040e7.
Zotero 插件